The gut metabolite indole-3-propionic acid activates ERK1 to restore social function and hippocampal inhibitory synaptic transmission in a 16p11.2 microdeletion mouse model

Jian Jiang,Dilong Wang,Youheng Jiang,Xiuyan Yang,Runfeng Sun,Jinlong Chang,Wenhui Zhu,Peijia Yao,Kun Song,Shuwen Chang,Hong Wang,Lei Zhou,Xue-Song Zhang,Huiliang Li,Ningning Li
DOI: https://doi.org/10.1186/s40168-024-01755-7
IF: 15.5
2024-03-30
Microbiome
Abstract:Microdeletion of the human chromosomal region 16p11.2 (16p11.2 ) is a prevalent genetic factor associated with autism spectrum disorder (ASD) and other neurodevelopmental disorders. However its pathogenic mechanism remains unclear, and effective treatments for 16p11.2  syndrome are lacking. Emerging evidence suggests that the gut microbiota and its metabolites are inextricably linked to host behavior through the gut-brain axis and are therefore implicated in ASD development. Despite this, the functional roles of microbial metabolites in the context of 16p11.2  are yet to be elucidated. This study aims to investigate the therapeutic potential of indole-3-propionic acid (IPA), a gut microbiota metabolite, in addressing behavioral and neural deficits associated with 16p11.2 , as well as the underlying molecular mechanisms.
microbiology
What problem does this paper attempt to address?